Celcuity Current Ratio 2016-2018 | CELC

Celcuity current ratio from 2016 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Celcuity Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.02B $0.00B 24.11
2018-06-30 $0.02B $0.00B 22.63
2018-03-31 $0.02B $0.00B 29.79
2017-12-31 $0.02B $0.00B 42.35
2017-09-30 $0.03B $0.00B 97.72
2017-06-30 $0.01B $0.00B 14.70
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.00
2015-12-31 $0.01B $0.00B 18.29
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.236B $0.000B
Celcuity Inc. is a cellular analysis company. It engaged in discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular activity driving a patient's cancer and the targeted therapy. Celcuity Inc. is based in Minneapolis, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $127.049B 14.36
Gilead Sciences (GILD) United States $88.639B 10.67
Biogen (BIIB) United States $68.008B 13.77
Celgene (CELG) United States $61.695B 11.97
Vertex Pharmaceuticals (VRTX) United States $47.708B 83.34
Illumina (ILMN) United States $44.906B 52.31
Regeneron Pharmaceuticals (REGN) United States $43.827B 22.20
Alexion Pharmaceuticals (ALXN) United States $24.927B 17.06
BioMarin Pharmaceutical (BMRN) United States $16.903B 0.00
Incyte (INCY) United States $16.761B 463.29
Seattle Genetics (SGEN) United States $11.532B 0.00
Exact Sciences (EXAS) United States $9.474B 0.00
BeiGene (BGNE) Cayman Islands $8.545B 0.00
QIAGEN (QGEN) Netherlands $8.278B 26.47
Alnylam Pharmaceuticals (ALNY) United States $8.140B 0.00
Sarepta Therapeutics (SRPT) United States $7.934B 0.00
Exelixis (EXEL) United States $7.191B 20.38
Bluebird Bio (BLUE) United States $6.601B 0.00
Bio-Techne Corp (TECH) United States $5.997B 40.51
Moderna (MRNA) United States $5.457B 0.00
Amarin (AMRN) Ireland $5.283B 0.00
Galapagos (GLPG) Belgium $5.277B 0.00
Alkermes (ALKS) Ireland $5.134B 3304.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.759B 0.00
Horizon Pharma Public (HZNP) Ireland $3.713B 15.28
Array BioPharma (ARRY) United States $3.688B 0.00
Guardant Health (GH) United States $3.437B 0.00
Immunomedics (IMMU) United States $3.432B 0.00
Allogene Therapeutics (ALLO) United States $3.395B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.344B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.323B 0.00
Emergent Biosolutions (EBS) United States $3.298B 27.78
Ascendis Pharma (ASND) Denmark $3.141B 0.00
Blueprint Medicines (BPMC) United States $2.903B 0.00
Ligand Pharmaceuticals (LGND) United States $2.801B 21.43
Akcea Therapeutics (AKCA) United States $2.735B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.668B 0.00
China Biologic Products (CBPO) China $2.665B 18.97
Ultragenyx Pharmaceutical (RARE) United States $2.590B 0.00
Genomic Health (GHDX) United States $2.520B 85.07
Global Blood Therapeutics (GBT) United States $2.442B 0.00
Repligen (RGEN) United States $2.423B 75.67
Halozyme Therapeutics (HALO) United States $2.313B 51.61
Amicus Therapeutics (FOLD) United States $2.270B 0.00
Myriad Genetics (MYGN) United States $2.194B 21.73
Reata Pharmaceuticals (RETA) United States $2.163B 0.00
Arena Pharmaceuticals (ARNA) United States $2.161B 0.00
Mirati Therapeutics (MRTX) United States $2.107B 0.00
Acceleron Pharma (XLRN) United States $2.029B 0.00
Denali Therapeutics (DNLI) United States $1.994B 0.00
Innoviva (INVA) United States $1.943B 10.99
AnaptysBio (ANAB) United States $1.888B 0.00
MyoKardia (MYOK) United States $1.853B 0.00
Allakos (ALLK) United States $1.837B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.837B 0.00
Insmed (INSM) United States $1.800B 0.00
Atara Biotherapeutics (ATRA) United States $1.658B 0.00
Spark Therapeutics (ONCE) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.573B 21.10
Vanda Pharmaceuticals (VNDA) United States $1.536B 122.04
Zai Lab Unsponsored ADR (ZLAB) China $1.495B 0.00
Medicines (MDCO) United States $1.465B 0.00
Cambrex (CBM) United States $1.435B 10.71
NeoGenomics (NEO) United States $1.423B 117.15
Biohaven Pharmaceutical Holding (BHVN) United States $1.409B 0.00
Aimmune Therapeutics (AIMT) United States $1.394B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.275B 0.00
Editas Medicine (EDIT) United States $1.262B 0.00
Myovant Sciences (MYOV) United Kingdom $1.249B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.241B 0.00
Clovis Oncology (CLVS) United States $1.229B 0.00
UniQure (QURE) Netherlands $1.182B 0.00
Rubius Therapeutics (RUBY) United States $1.169B 0.00
Lion Biotechnologies (IOVA) United States $1.160B 0.00
Sangamo Therapeutics (SGMO) United States $1.157B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.123B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.093B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.090B 0.00
Fate Therapeutics (FATE) United States $1.056B 0.00
Solid Biosciences (SLDB) United States $1.055B 0.00
Audentes Therapeutics (BOLD) United States $1.054B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.002B 0.00
Retrophin (RTRX) United States $0.964B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.947B 0.00
Puma Biotechnology (PBYI) United States $0.923B 0.00
Apellis Pharmaceuticals (APLS) United States $0.835B 0.00
Coherus BioSciences (CHRS) United States $0.829B 0.00
InflaRx (IFRX) Germany $0.826B 0.00
Novavax (NVAX) United States $0.812B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.805B 0.00
Acorda Therapeutics (ACOR) United States $0.788B 9.98
Alder BioPharmaceuticals (ALDR) United States $0.784B 0.00
Epizyme (EPZM) United States $0.776B 0.00
AC Immune SA (ACIU) Switzerland $0.769B 0.00
Vericel (VCEL) United States $0.768B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.768B 0.00
Athenex (ATNX) United States $0.767B 0.00
CytomX Therapeutics (CTMX) United States $0.764B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
Revance Therapeutics (RVNC) United States $0.747B 0.00
Principia Biopharma (PRNB) United States $0.739B 0.00
G1 THERAPEUTICS (GTHX) United States $0.734B 0.00
Intra-Cellular Therapies (ITCI) United States $0.725B 0.00
Cellectis (CLLS) France $0.695B 0.00
UNITY Biotechnology (UBX) $0.695B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.693B 0.00
UROGEN PHARMA (URGN) Israel $0.693B 0.00
Heska (HSKA) United States $0.686B 56.15
Dicerna Pharmaceuticals (DRNA) United States $0.682B 0.00
Kura Oncology (KURA) United States $0.642B 0.00
RA PHARMCTL INC (RARX) United States $0.635B 0.00
ANI Pharmaceuticals (ANIP) United States $0.630B 12.06
Twist Bioscience (TWST) United States $0.629B 0.00
Intellia Therapeutics (NTLA) United States $0.619B 0.00
Viking Therapeutics (VKTX) United States $0.609B 0.00
Aptinyx (APTX) United States $0.597B 0.00
Cara Therapeutics (CARA) United States $0.597B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.585B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.572B 0.00
Arvinas (ARVN) United States $0.521B 0.00
Zymeworks (ZYME) Canada $0.517B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.502B 0.00
ObsEva SA (OBSV) Switzerland $0.501B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.500B 0.00
Anika Therapeutics (ANIK) United States $0.484B 20.05
Gritstone Oncology (GRTS) United States $0.482B 0.00
Prothena (PRTA) Ireland $0.480B 0.00
Eidos Therapeutics (EIDX) United States $0.476B 0.00
DBV Technologies (DBVT) France $0.471B 0.00
Osiris Therapeutics (OSIR) United States $0.466B 0.00
PDL BioPharma (PDLI) United States $0.461B 7.52
Kezar Life Sciences (KZR) United States $0.454B 0.00
Inovio Pharmaceuticals (INO) United States $0.451B 0.00
Mesoblast (MESO) Australia $0.443B 0.00
Arcus Biosciences (RCUS) United States $0.436B 0.00
BeyondSpring (BYSI) United States $0.422B 0.00
Evelo Biosciences (EVLO) United States $0.422B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.415B 0.00
Scholar Rock Holding (SRRK) United States $0.413B 0.00
MediciNova (MNOV) United States $0.405B 0.00
Synthorx (THOR) United States $0.404B 0.00
Senesco Technologies (ELOX) United States $0.400B 0.00
Zealand Pharma (ZEAL) Denmark $0.400B 4.41
Cytokineticsorporated (CYTK) United States $0.384B 0.00
Kindred Biosciences (KIN) United States $0.379B 0.00
Agenus (AGEN) United States $0.377B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.372B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Krystal Biotech (KRYS) United States $0.365B 0.00
Five Prime Therapeutics (FPRX) United States $0.363B 0.00
Abeona Therapeutics (ABEO) United States $0.346B 0.00
AVROBIO (AVRO) United States $0.343B 0.00
Replimune (REPL) United States $0.333B 0.00
Cellular Biomedicine (CBMG) United States $0.332B 0.00
Stemline Therapeutics (STML) United States $0.316B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.310B 0.00
Kodiak Sciences (KOD) United States $0.309B 0.00
Merus (MRUS) Netherlands $0.308B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.302B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.301B 0.00
BioDelivery Sciences (BDSI) United States $0.293B 0.00
Albireo Pharma (ALBO) United States $0.290B 0.00
Enochian Biosciences (ENOB) United States $0.289B 0.00
Sorrento Therapeutics (SRNE) United States $0.278B 0.00
Urovant Sciences (UROV) United States $0.275B 0.00
Kadmon Holdings (KDMN) United States $0.275B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
Gamida Cell (GMDA) Israel $0.257B 0.00
Verastem (VSTM) United States $0.254B 0.00
Seres Therapeutics (MCRB) United States $0.253B 0.00
Liquidia Technologies (LQDA) United States $0.251B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.249B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.243B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.239B 0.00
Axsome Therapeutics (AXSM) United States $0.237B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
ResTORbio (TORC) United States $0.227B 0.00
Aduro Biotech (ADRO) United States $0.226B 0.00
PSivida (EYPT) United States $0.224B 0.00
Magenta Therapeutics (MGTA) United States $0.222B 0.00
MannKind (MNKD) United States $0.220B 0.00
Celyad SA (CYAD) Belgium $0.216B 0.00
Kamada (KMDA) Israel $0.215B 19.74
Syros Pharmaceuticals (SYRS) United States $0.213B 0.00
Kala Pharmaceuticals (KALA) United States $0.211B 0.00
Adverum Biotechnologies (ADVM) United States $0.210B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.206B 0.00
Athersys (ATHX) United States $0.206B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.205B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.195B 0.00
Geron (GERN) United States $0.194B 0.00
XBiotech (XBIT) United States $0.194B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
LogicBio Therapeutics (LOGC) United States $0.187B 0.00
Equillium (EQ) United States $0.184B 0.00
Synlogic (SYBX) United States $0.183B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.181B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
TOCAGEN INC (TOCA) United States $0.178B 0.00
Cerecor (CERC) United States $0.176B 0.00
Allena Pharmaceuticals (ALNA) United States $0.171B 0.00
Cohbar (CWBR) United States $0.169B 0.00
VBI Vaccines (VBIV) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
Constellation Pharmaceuticals (CNST) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
ADMA Biologics Inc (ADMA) United States $0.150B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Unum Therapeutics (UMRX) United States $0.148B 0.00
Motif Bio Plc (MTFB) United States $0.146B 0.00
Palatin Technologies (PTN) United States $0.144B 17.74
BioTime (BTX) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Spero Therapeutics (SPRO) United States $0.140B 0.00
Checkpoint Therapeutics (CKPT) United States $0.135B 0.00
Axovant Sciences (AXON) United Kingdom $0.132B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.125B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.122B 0.00
Cocrystal Pharma (COCP) United States $0.120B 133.33
XOMA (XOMA) United States $0.119B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.117B 0.00
Proteostasis Therapeutics (PTI) United States $0.116B 0.00
OvaScience (MLND) United States $0.114B 0.00
Cue Biopharma (CUE) United States $0.113B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
NantKwest (NK) United States $0.108B 0.00
ETON PHARMACEUT (ETON) United States $0.107B 0.00
Signal Genetics (MGEN) United States $0.103B 0.00
Neothetics (EVFM) United States $0.102B 0.00
VTv Therapeutics (VTVT) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.097B 0.00
Mersana Therapeutics (MRSN) United States $0.092B 0.00
PHASEBIO PHARMA (PHAS) United States $0.090B 0.00
Mustang Bio (MBIO) United States $0.088B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.085B 0.00
Anavex Life Sciences (AVXL) United States $0.085B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.085B 0.00
Chiasma (CHMA) United States $0.085B 0.00
Cidara Therapeutics (CDTX) United States $0.085B 0.00
Aptose Biosciences (APTO) Canada $0.085B 0.00
Cel-Sci (CVM) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.082B 0.00
OVID THERAPEUTC (OVID) United States $0.082B 0.00
VolitionRX (VNRX) Singapore $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
ITUS (ANIX) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Fortress Biotech (FBIO) United States $0.073B 0.00
ScPharmaceuticals (SCPH) United States $0.072B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.50
Merrimack Pharmaceuticals (MACK) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
Eleven Biotherapeutics (SESN) United States $0.061B 0.00
Alimera Sciences (ALIM) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Ophthotech (OPHT) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Monster Digital (INNT) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Alcobra (ARCT) United States $0.055B 0.00
Adial Pharmaceuticals (ADIL) United States $0.055B 0.00
Bellerophon Therapeutics (BLPH) United States $0.054B 0.00
Evogene (EVGN) Israel $0.054B 0.00
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Selecta Biosciences (SELB) United States $0.051B 0.00
Vaccinex (VCNX) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Proteon Therapeutics (PRTO) United States $0.047B 0.00
Arsanis (ASNS) United States $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.045B 0.00
Versartis (ARAV) United States $0.044B 3.86
OncoSec Medical (ONCS) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Trevena (TRVN) United States $0.042B 0.00
Asterias Biotherapeutics (AST) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.039B 0.00
Celsion (CLSN) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Clearside Biomedical (CLSD) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.035B 0.00
Galena Biopharma (SLS) United States $0.034B 0.00
Curis (CRIS) United States $0.033B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.032B 0.00
Sophiris Bio (SPHS) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Oragenics (OGEN) United States $0.029B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.029B 4.75
Zosano Pharma (ZSAN) United States $0.028B 0.00
Eyenovia (EYEN) United States $0.027B 0.00
IMMURON LTD (IMRN) Australia $0.027B 0.00
TRACON Pharmaceuticals (TCON) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
BioPharmX (BPMX) United States $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
GTx (GTXI) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Vical (VICL) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
IBio (IBIO) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Aileron Therapeutics (ALRN) United States $0.017B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Advaxis (ADXS) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Benitec Biopharma (BNTC) Australia $0.015B 0.00
Cellect Biotechnology (APOP) Israel $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.61
Genetic Technologies (GENE) Australia $0.013B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Neuralstem (CUR) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00